Stero Biotechs, in a collaboration with its main partner and shareholder, Mor Research Applications announced a new clinical trial in the global efforts of fighting the COVID-19 virus.
Stero Biotechs received its second Helsinki approval to move forward with a second Phase 2a clinical trial. The trial will be a randomized, double-blind, placebo-controlled, multicenter study of ST-SDCD-01 ...